Quanterix is on a mission to change the way in which healthcare is provided by giving researchers the ability to closely examine the continuum from health to disease. In order to make this vision a reality, they've brought together the most experienced management team, renowned scientists, industry leading investors and expert advisors, to form a collaborative ecosystem, united through the common goal of advancing the science of precision health.
Their flagship technology, the SIngle MOlecule Array (Simoa) is an ultra-sensitive immunoassay technology that allows detection of proteins and nucleic acids at lowest possible levels. This gives researchers the ability to examine critical biomarkers, even at baseline levels in most common sample types. Using the fully automated HD-X instrument, it is possible to measure up to six biomarkers in a single sample with high reproducibility.